000 | 01913 a2200553 4500 | ||
---|---|---|---|
005 | 20250517131158.0 | ||
264 | 0 | _c20171003 | |
008 | 201710s 0 0 eng d | ||
022 | _a1348-4540 | ||
024 | 7 |
_a10.1507/endocrj.EJ16-0319 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aAriga, Miyako | |
245 | 0 | 0 |
_aGlucose deprivation attenuates sortilin levels in skeletal muscle cells. _h[electronic resource] |
260 |
_bEndocrine journal _cMar 2017 |
||
300 |
_a255-268 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article | ||
650 | 0 | 4 |
_aAdaptor Proteins, Vesicular Transport _xagonists |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBlood Glucose _xanalysis |
650 | 0 | 4 | _aCell Differentiation |
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 |
_aDiabetes Mellitus, Experimental _xblood |
650 | 0 | 4 |
_aDown-Regulation _xdrug effects |
650 | 0 | 4 |
_aFasting _xmetabolism |
650 | 0 | 4 | _aFood Deprivation |
650 | 0 | 4 |
_aGlucose _xmetabolism |
650 | 0 | 4 | _aHindlimb |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMechanistic Target of Rapamycin Complex 1 |
650 | 0 | 4 |
_aMultiprotein Complexes _xantagonists & inhibitors |
650 | 0 | 4 |
_aMuscle Cells _xcytology |
650 | 0 | 4 |
_aMuscle, Skeletal _xcytology |
650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
650 | 0 | 4 |
_aRNA, Messenger _xmetabolism |
650 | 0 | 4 | _aRats, Wistar |
650 | 0 | 4 |
_aSirolimus _xpharmacology |
650 | 0 | 4 |
_aTOR Serine-Threonine Kinases _xantagonists & inhibitors |
650 | 0 | 4 |
_aUp-Regulation _xdrug effects |
700 | 1 | _aYoneyama, Yosuke | |
700 | 1 | _aFukushima, Toshiaki | |
700 | 1 | _aIshiuchi, Yuri | |
700 | 1 | _aIshii, Takayuki | |
700 | 1 | _aSato, Hitoshi | |
700 | 1 | _aHakuno, Fumihiko | |
700 | 1 | _aNedachi, Taku | |
700 | 1 | _aTakahashi, Shin-Ichiro | |
773 | 0 |
_tEndocrine journal _gvol. 64 _gno. 3 _gp. 255-268 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1507/endocrj.EJ16-0319 _zAvailable from publisher's website |
999 |
_c26701845 _d26701845 |